Clinical trial

Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial

NCT01442428

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2014-01-01

PhasePHASE2 / PHASE3

Study timeline

Study start (unknown)2014-01-01Date precision: month

Registry last updated2013-11-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Immune Reconstitution Inflammatory Syndromeunresolved

Immune Reconstitution Syndromeunresolved

Tuberculosisunresolved

HIV-infection/Aidsunresolved

Interventions

DexamethasoneDRUG · verified · RxNorm: dexamethasone

AtorvastatinDRUG · verified · RxNorm: atorvastatin

NaproxenDRUG · verified · RxNorm: naproxen

Sponsors & collaborators

University of Minnesotalead sponsor

Pfizercollaborator

Minnesota Medical Foundationcollaborator

Mapped research locations

BangkokThailand1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01442428 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.